The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline TP53m AML patients: Phase 1b results.
 
Naval Guastad Daver
Consulting or Advisory Role - Abbvie; Agios; Amgen; Arog; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech; Gilead Sciences; Immunogen; Jazz Pharmaceuticals; Novartis; Pfizer; SERVIER; Shattuck Labs; Syndax; Trillium Therapeutics
Research Funding - Abbvie; Amgen; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; FATE Therapeutics; Genentech; Gilead Sciences; Glycomimetics; Hanmi; Immunogen; Novimmune; Pfizer; Servier; Trillium Therapeutics; Trovagene
 
Paresh Vyas
Honoraria - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Pfizer
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent for flow cytometric detection of leukaemic stem cells
 
Suman Kambhampati
No Relationships to Disclose
 
Monzr M. Al Malki
Consulting or Advisory Role - CareDX; Gilead Sciences; Hansa Biopharma; Medexus Pharmaceuticals; NexImmune; Stemline Therapeutics
Research Funding - CareDX (Inst); Gilead Sciences (Inst); Incyte (Inst); NexImmune (Inst)
 
Richard A. Larson
Consulting or Advisory Role - Actinium Pharmaceuticals; ARIAD; Celgene; CVS Caremark; Epizyme; Immunogen; Novartis; SERVIER
Research Funding - Astellas Pharma (Inst); Celgene (Inst); Cellectis (Inst); Daiichi Sankyo (Inst); Gilead/Forty Seven; Novartis (Inst); Rafael Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Adam Steven Asch
Research Funding - Astellas Pharma (Inst); Cartesian Therapeutics (Inst); Forty Seven (Inst); Gilead Sciences (Inst); Juno Therapeutics (Inst); Macrogenics (Inst); MEI Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Provisional patent submitted (I)
 
Gabriel N. Mannis
Consulting or Advisory Role - Abbvie/Genentech; Agios; Astellas Pharma; Bristol-Myers Squibb/Celgene; Forty Seven; Macrogenics; SERVIER; Stemline Therapeutics
Research Funding - Astex Pharmaceuticals (Inst); Forty Seven (Inst); Gilead Sciences (Inst); Glycomimetics (Inst); Immune-Onc Therapeutics (Inst); Jazz Pharmaceuticals (Inst); Syndax (Inst)
 
Wanxing Chai-Ho
Consulting or Advisory Role - SERVIER
 
Tiffany N. Tanaka
Honoraria - OncLive
Consulting or Advisory Role - CTI BioPharma Corp
 
Terrence J. Bradley
Consulting or Advisory Role - Abbvie; Novartis
 
Deepa Jeyakumar
Research Funding - Jazz Pharmaceuticals; Pfizer
 
Eunice S. Wang
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene/Bristol-Myers Squibb; Genentech; Gilead Sciences; GlaxoSmithKline; Jazz Pharmaceuticals; Kite/Gilead; Novartis; Pfizer; Pharmaessentia; PTC Therapeutics; Stemline Therapeutics; Takeda
Speakers' Bureau - Astellas Pharma; dava oncology; Kite, a Gilead company; Pfizer; Stemline Therapeutics
 
Guan Xing
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Mark Chao
Employment - Forty Seven; Gilead Sciences; TenSixteen Bio
Leadership - Forty Seven; TenSixteen Bio
Stock and Other Ownership Interests - Chimera Bioengineering; Forty Seven; Gilead Sciences; Hepatx; TenSixteen Bio; TigaTx
Honoraria - D2G Oncology
Consulting or Advisory Role - Chimera Bioengineering
Patents, Royalties, Other Intellectual Property - I am an inventor on patents licensed to Hepatx Inc.; I am an inventor on several patents from Stanford University that have been licensed to Forty Seven, Inc. I am also an inventor on patents generated from Forty Seven, Inc.
Travel, Accommodations, Expenses - Forty Seven; Gilead Sciences; TenSixteen Bio
 
Giridharan Ramsingh
Employment - Gilead Sciences; Gilead Sciences
Stock and Other Ownership Interests - Genentech/Roche; Gilead Sciences
 
Camille Renard
Employment - Gilead Sciences; Google
Stock and Other Ownership Interests - Alphabet; Gilead Sciences
 
Indu Lal
Employment - Abbvie/Pharmacyclics; Gilead Sciences; The Permanente Medical Group NorCal (I)
Stock and Other Ownership Interests - Abbvie; Gilead Sciences; Reviva Pharmaceuticals (I)
 
Joshua F. Zeidner
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Genentech; Gilead Sciences; SERVIER; Shattuck Labs; Takeda
Research Funding - Arog (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Gilead Sciences (Inst); Merck (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Agios; Celgene; Daiichi Sankyo; Dava Oncology; Forty Seven; Takeda; Tolero Pharmaceuticals
 
David Andrew Sallman
Consulting or Advisory Role - Abbvie; Bluebird Bio; Bristol-Myers Squibb; Gilead Sciences; Intellia Therapeutics; Janssen; Kite, a Gilead company; Magenta Therapeutics; Molecular Partners; Novartis; Servier; Shattuck Labs; Syndax; Syros Pharmaceuticals; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Incyte; SERVIER
Research Funding - Aprea Therapeutics (Inst); Jazz Pharmaceuticals